3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
East Asian patients may metabolize Prometrium (micronized progesterone) differently due to CYP2C19 genetic variants common in that population. This guide reviews pharmacogenomic evidence, its limits, and practical monitoring considerations, pending qualified clinical review.
A deep dive into how ethnicity, CYP enzyme variants, insulin resistance, and diabetes prevalence may alter Prometrium (micronized progesterone) efficacy in Hispanic and Latino patients, with dosing implications.
Evidence-based review of how micronized progesterone (Prometrium) performs in South Asian populations, including pharmacogenomic factors, metabolic interactions, and clinical dosing guidance.